Public recall detail

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.

2025-02-18

medium
Recall Safety notice
Quick summary

Quick summary: CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.. Date: 2025-02-18.

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.. Date: 2025-02-18.

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brandomega laboratories, CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
ProductCISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
IssueHealth products - Product quality
Recall classType III
IdentificationRA-76972

Affected products

BrandCISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
ProductCISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
DIN / NPN / authorizationDIN 02408813
Dosage formSolution
StrengthCisatracurium (Cisatracurium besilate) 2mg/ml
LotB3L78VA, B3M79VA

Issue

The level of the degradation product Benzaldehyde is out of specification in the affected lots.

What you should do

  • Verify if your product is affected.
  • Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  • Contact the recalling firm if you have any questions about the recall.
  • Report any health product related side effects to Health Canada.
  • Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesOmega Laboratories Ldt. 11177 rue Hamon Montréal, QC H3M 3E4
Published byHealth Canada
Recall classType III
Alert / recall typeHealth product recall
Identification numberRA-76972
Background{}
CompaniesOmega Laboratories Ldt. 11177 rue Hamon Montréal, QC H3M 3E4
AudiencesGeneral public Healthcare Industry
Source updated2025-02-18

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...